Pfizer (NYSE:PFE)

road fork sign

Pfizer Decides Against the Split

Pfizer Inc. (NYSE: PFE) shares traded down marginally Monday morning after the company announced that it will abandon its plan to split into two companies. This pharma giant has decided against this ...
Read Full Story »
Pfizer

5 Dividend Paying Stocks Deutsche Bank Likes If Trump Wins in November

The good news for all of us is that in about seven weeks the political cycle will be over, at least as far as the presidential election is concerned, and ...
Read Full Story »
Federal Reserve

Fed Won’t Raise Until December: Buy These 4 Dividend Blue Chips On Sale

The market has shifted back and forth the past three trading days on basically one issue: the Federal Reserve will raise rates at their meeting next week. While the argument ...
Read Full Story »
clinical trials

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward. One key analyst issued a few of its top picks ...
Read Full Story »
Prescription drugs

Major Pharma Continues to See Significant Drop in Short Interest

The short interest data have been released for the August 31 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
bigger fish

3 Biotech Stocks Could Be the Next Big Takeover Targets

Just as the biotech segment was starting to regain lost ground, and was fast approaching 2016 highs, yet another speed bump was hit. The EpiPen controversy, and the resulting commentary again ...
Read Full Story »
Prescription drugs

Major Pharma Short Interest Faces Significant Drop

The short interest data have been released for the August 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Prescription drugs

Pfizer Pays a Big Premium for Medivation

In one of the longest running bidding wars in recent times, Pfizer Inc. (NYSE: PFE) has finally reeled in cancer-drug maker Medivation Inc. (NASDAQ: MDVN) for a whopping $81.50 a ...
Read Full Story »
money

How Much Medivation Can Really Fetch in a Buyout

Medivation Inc. (NASDAQ: MDVN) has been among the top future biotech mergers for quite some time. The problem is that we still have no idea which company will buy Medivation, ...
Read Full Story »
thinkstockphotos-522646895

3M, Chevron Pull Dow Higher Wednesday

August 17, 2016: Markets opened slightly lower Wednesday following a slide in European markets. Utility stocks were the leading sector while consumer discretionary stocks weighed most heavily. WTI crude oil ...
Read Full Story »
bull and bear

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

It is sometimes hard to wonder about health care and pharmaceutical stocks during an election year. Still, with uncertainty can come opportunity. The team at Credit Suisse has issued its ...
Read Full Story »
buy sell stocks

10 Merrill Lynch Equity Income Portfolio Picks for Safe High-Dividend Yields

With interest rates at embarrassingly low levels and with stocks at all-time highs, many investors have turned to key dividend-paying stocks to generate income and hopefully to achieve long-term upside. ...
Read Full Story »
NYSE

5 DJIA Stocks That Really Missed Out on the All-Time High Rally Thursday

The Dow Jones Industrial Average hit yet another all-time high on Thursday, August 11, 2016. What is amazing is that the rising tide did not actually lift all ships. There ...
Read Full Story »
Medicine pills

Major Pharma Short Interest Slides

The short interest data have been released for the July 29 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
dividends

Short Sellers Look Worried About High-Yield Defensive Dividend Stocks

The short interest data for the July 29 settlement date are out. Investors and traders alike need to know that the short sellers are now fighting the market at all-time highs. ...
Read Full Story »